drugset / Trial / NCT04712006

A Study of JNJ-64304500 Following Subcutaneous Injection in Healthy Chinese Adult Participants

NCT04712006

Non-randomizedSequentialOpen-labelTreatment

Summary

The purpose of this study is to assess the pharmacokinetic following single subcutaneous administration of Dose 1 or Dose 2 of JNJ-64304500 in healthy Chinese adult participants.

Timeline

Start
2021-05-30
Primary completion
2021-08-27
Completion
2021-10-30

Drugs

EvaluationDrugModalityDoseRoute
Subject JNJ-64304500 Unknown Subcutaneous

Indications

No indication recorded.